Inhibition of wildtype PI3Kα signaling is required for durable efficacy in PI3Kα mutant cancer cells due to robust reactivation of wild-type PI3Kα signaling

被引：0
|
作者：
MacDougall, John R.
Zhong, Mengqi
Merritt, Hanne
Del Cid, Joselyn S.
Bradley, John
Mak, Raymond
Dhawan, Neil
Chen, Wei
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4945
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4945
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PI3K Signaling in Neutrophils
    Hawkins, Phillip T.
    Stephens, Len R.
    Suire, Sabine
    Wilson, Michael
    [J]. PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 1, 2010, 346 : 183 - 202
  • [2] The Role of PI3kγ and PI3kΔ in Alloimmunity
    Uehara, M.
    Jamil, A.
    Solhjou, Z.
    McGrath, M.
    Banouni, N.
    Evans, C.
    Dinitto, J.
    Winkler, D.
    Abdi, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 325 - 325
  • [3] The role of PI3kγ and PI3kδ in alloimmunity
    Uehara, Mayuko
    Jamil, Azzi
    Ohori, Shunsuke
    Solhjou, Zhabiz
    McGrath, Martina
    Banouni, Naima M.
    Evans, Catherine A.
    Dinitto, Jonathan P.
    Winkler, David G.
    Abdi, Reza
    [J]. TRANSPLANTATION, 2016, 100 (07) : S361 - S361
  • [4] Targeting PI3K/mTOR signaling in cancer
    Arcaro, Alexandre
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [5] Targeting the PI3K signaling pathway in cancer
    Wong, Kwok-Kin
    Engelman, Jeffrey A.
    Cantley, Lewis C.
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2010, 20 (01) : 87 - 90
  • [6] PI3K signaling in cancer: beyond AKT
    Lien, Evan C.
    Dibble, Christian C.
    Toker, Alex
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2017, 45 : 62 - 71
  • [7] Targeting PI3K/mTOR Signaling in Cancer
    Emerling, Brooke M.
    Akcakanat, Argun
    [J]. CANCER RESEARCH, 2011, 71 (24) : 7351 - 7359
  • [8] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    [J]. Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [9] NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations
    Serra, Violeta
    Markman, Ben
    Scaltriti, Maurizio
    Eichhorn, Pieter J. A.
    Valero, Vanesa
    Guzman, Marta
    Luisa Botero, Maria
    Llonch, Elisabeth
    Atzori, Francesco
    Di Cosimo, Serena
    Maira, Michel
    Garcia-Echeverria, Carlos
    Lluis Parra, Josep
    Arribas, Joaquin
    Baselga, Jose
    [J]. CANCER RESEARCH, 2008, 68 (19) : 8022 - 8030
  • [10] The Neurodevelopmental Implications of PI3K Signaling
    Waite, Kathryn
    Eickholt, Britta J.
    [J]. PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 1, 2010, 346 : 245 - 265
12345